MECOM and acute myeloid leukemia: We observed that IL12Rβ2 KD impaired the colony formation not only in EVI1+ OCI-AML4 cells but also in EVI1- MOLM13, THP1 and HL60 cells, indicating a potential role as driver and putative therapeutic target in AML.